Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# # robots.txt # # This file is to prevent the crawling and indexing of certain parts # of your site by web crawlers and spiders run by sites like Yahoo! # and Google. By telling these "robots" where not to go on your site, # you save bandwidth and server resources. # # This file will be ignored unless it is at the root of your host: # Used: http://example.com/robots.txt # Ignored: http://example.com/site/robots.txt # # For more information about the robots.txt standard, see: # http://www.robotstxt.org/robotstxt.html User-agent: * Crawl-delay: 10 # CSS, JS, Images Allow: /misc/*.css$ Allow: /misc/*.css? Allow: /misc/*.js$ Allow: /misc/*.js? Allow: /misc/*.gif Allow: /misc/*.jpg Allow: /misc/*.jpeg Allow: /misc/*.png Allow: /modules/*.css$ Allow: /modules/*.css? Allow: /modules/*.js$ Allow: /modules/*.js? Allow: /modules/*.gif Allow: /modules/*.jpg Allow: /modules/*.jpeg Allow: /modules/*.png Allow: /profiles/*.css$ Allow: /profiles/*.css? Allow: /profiles/*.js$ |
Title | Welcome to ScanCLAD | |
Description | ScanCLAD is an investigator initiated, controlled, randomized, open-label, and multi-centre study evaluating if once-daily tacrolimus or twice-daily cyclosporin, reduces the 3-year incidence of Chronic Lung Allograft Dysfunction after lung |
Keywords | N/A |
WebSite | scanclad.se |
Host IP | 91.201.60.17 |
Location | Sweden |
Site | Rank |
US$1,737
Last updated: 2022-12-19 23:57:36
scanclad.se has Semrush global rank of 0. scanclad.se has an estimated worth of US$ 1,737, based on its estimated Ads revenue. scanclad.se receives approximately 200 unique visitors each day. Its web server is located in Sweden, with IP address 91.201.60.17. According to SiteAdvisor, scanclad.se is safe to visit. |
Purchase/Sale Value | US$1,737 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$48 |
Yearly Ads Revenue | US$577 |
Daily Unique Visitors | 13 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
scanclad.se. | A | 7199 | IP: 91.201.60.17 |
scanclad.se. | NS | 21600 | NS Record: dns3.oderland.com. |
scanclad.se. | NS | 21600 | NS Record: dns2.oderland.com. |
scanclad.se. | NS | 21600 | NS Record: dns1.oderland.com. |
scanclad.se. | MX | 7200 | MX Record: 1 mx1.oderland.com. |
scanclad.se. | MX | 7200 | MX Record: 1 mx2.oderland.com. |
scanclad.se. | TXT | 7200 | TXT Record: v=spf1 +a +mx +ip4:91.201.60.17 +include:_vsp.oderland.com ~all |
Skip to main content Home ScanCLAD Contact Log In Welcome to ScanCLAD ScanCLAD is an investigator initiated, controlled, randomized, open-label, and multi-centre study evaluating if once-daily tacrolimus or twice-daily cyclosporin, reduces the 3-year incidence of Chronic Lung Allograft Dysfunction after lung transplantation (EudraCT number 2015-004137-27) The study started in the end of 2016, and is planned to continue through 2022 for follow up of all patients. It is carried out as a collaboration between five University Hospitals in Scandinavia: Sahlgrenska University Hospital in Gothenburg, Sweden Skåne University Hospital in Lund, Sweden Rigshospitalet in Copenhagen, Denmark Oslo University Hospital in Oslo, Norway Helsinki University Hospital in Helsinki, Finland This home page has primarily been set up as a tool for communication between the people involved in conducting this study. "The ScanCLAD study has the potential to become one of the most important studies on |
HTTP/1.1 302 Found Connection: Keep-Alive Keep-Alive: timeout=5, max=100 date: Mon, 19 Sep 2022 08:42:43 GMT server: LiteSpeed cache-control: no-cache, no-store, must-revalidate, max-age=0 location: http://scanclad.se/cgi-sys/suspendedpage.cgi HTTP/1.1 200 OK Connection: Keep-Alive Keep-Alive: timeout=5, max=100 content-type: text/html date: Mon, 19 Sep 2022 08:42:43 GMT server: LiteSpeed |
# state: active domain: scanclad.se holder: fghnqr1013-00001 created: 2017-10-13 modified: 2021-09-13 expires: 2023-10-13 nserver: dns3.oderland.com nserver: dns2.oderland.com nserver: dns1.oderland.com dnssec: signed delegation registry-lock: unlocked status: ok registrar: ODERLAND |